BE Studies involving Multiple Groups [General Sta­tis­tics]

posted by Dr_Dan  – Germany, 2014-08-11 01:59 (4338 d 13:13 ago) – Posting: # 13359
Views: 6,103

Dear John

❝ What if the drug is HVD?


The same applies. Your 90%CI will be even wider due to the high variability of the drug and the low number of subjects and you will certainly get only a partial overlap with the acceptance range.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
350 visitors (0 registered, 350 guests [including 25 identified bots]).
Forum time: 15:12 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5